SPONSOR
Masonic Cancer Center, University of Minnesota
Total Trials
5
Recruiting
5
Phases
Phase 2, Phase 1
Conditions studied: Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaBiphenotypic Acute LeukemiaUndifferentiated LeukemiaProlymphocytic LeukemiaChronic Myelogenous LeukemiaPlasma Cell LeukemiaMyelodysplastic SyndromesLeukemia, MyeloidMyelodysplastic Syndrome With Excess Blasts-1
NCT05805605 Phase 2
Recruiting
Allo HSCT Using RIC and PTCy for Hematological Diseases
Acute Myelogenous Leukemia
NCT06594445 Phase 1
Recruiting
HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML
Myeloid Malignancy
NCT06342986 Phase 1
Recruiting
Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
Gynecologic Cancer
NCT02161783
Recruiting
Treatment of Graft Failure After Hematopoietic Stem Cell Transplantation
Primary Graft Failure
NCT06412497 Phase 2
Recruiting
MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.
Severe Aplastic Anemia